RxDoctor Payments Data

Sheree Waterous

Medical · Atlantis, FLNPI 1285701060

Payments from drug & device makers

$3,373in general payments, 2019–2025

Across 152 payments — averaging $22.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$761
  • Lilly USA, LLC$648
  • Novo Nordisk$334
  • Esperion Therapeutics, Inc.$226
  • Exact Sciences$173
  • AbbVie$169
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,373 in reported general payments places this provider in the 80th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$37,433
MounjaroTirzepatide26$26,468
JardianceEmpagliflozin25$25,023
Repatha SureclickEvolocumab12$9,381
Levothyroxine Sodium119$1,627
SynthroidLevothyroxine Sodium15$1,444
Atorvastatin Calcium141$1,226
Rosuvastatin Calcium110$1,214
Metoprolol Succinate67$1,058
Losartan Potassium112$1,050
Amlodipine Besylate105$971
Escitalopram Oxalate62$899
Gabapentin41$834
Valsartan22$711
Pantoprazole Sodium57$696

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$334$37,43330 claims
Lilly USA, LLCMounjaro$648$26,46826 claims
Boehringer IngelheimJardiance$92$25,02325 claims
AbbVieSynthroid$169$1,44415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,031 medical providers in Florida.

Other medical in Atlantis

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →